Skin toxicities are common with targeted therapies for GI malignancies but can be remedied by preventive measures and a collaboration with dermatology.
Rona Yaeger, MD
Advertisement
Articles by Rona Yaeger, MD
Advertisement
Latest Updated Articles
Identifying Common Toxicities With Targeted Therapies in GI MalignanciesNovember 16th 2025
Advertisement
Advertisement
Trending on CancerNetwork
1
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
2
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
3
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
4
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
5